MARINEMAX INC (HZO) Stock Fundamental Analysis

NYSE:HZO • US5679081084

30.5 USD
+0.45 (+1.5%)
At close: Feb 27, 2026
30.5 USD
0 (0%)
After Hours: 2/27/2026, 8:09:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall HZO gets a fundamental rating of 3 out of 10. We evaluated HZO against 123 industry peers in the Specialty Retail industry. HZO has a bad profitability rating. Also its financial health evaluation is rather negative. HZO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • HZO had positive earnings in the past year.
  • HZO had a positive operating cash flow in the past year.
  • Of the past 5 years HZO 4 years were profitable.
  • In multiple years HZO reported negative operating cash flow during the last 5 years.
HZO Yearly Net Income VS EBIT VS OCF VS FCFHZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • The Return On Assets of HZO (-2.37%) is worse than 62.60% of its industry peers.
  • Looking at the Return On Equity, with a value of -6.18%, HZO is in line with its industry, outperforming 46.34% of the companies in the same industry.
  • HZO's Return On Invested Capital of 2.27% is in line compared to the rest of the industry. HZO outperforms 47.15% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HZO is significantly below the industry average of 11.89%.
Industry RankSector Rank
ROA -2.37%
ROE -6.18%
ROIC 2.27%
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
HZO Yearly ROA, ROE, ROICHZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • Looking at the Operating Margin, with a value of 2.94%, HZO is in line with its industry, outperforming 56.10% of the companies in the same industry.
  • In the last couple of years the Operating Margin of HZO has declined.
  • The Gross Margin of HZO (31.59%) is worse than 60.16% of its industry peers.
  • In the last couple of years the Gross Margin of HZO has grown nicely.
Industry RankSector Rank
OM 2.94%
PM (TTM) N/A
GM 31.59%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
HZO Yearly Profit, Operating, Gross MarginsHZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HZO is destroying value.
  • HZO has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HZO remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for HZO is higher compared to a year ago.
HZO Yearly Shares OutstandingHZO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
HZO Yearly Total Debt VS Total AssetsHZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.84 indicates that HZO is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HZO has a Altman-Z score (1.84) which is in line with its industry peers.
  • HZO has a debt to FCF ratio of 5.88. This is a neutral value as HZO would need 5.88 years to pay back of all of its debts.
  • HZO has a Debt to FCF ratio of 5.88. This is in the better half of the industry: HZO outperforms 60.16% of its industry peers.
  • HZO has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.13, HZO is in line with its industry, outperforming 41.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 5.88
Altman-Z 1.84
ROIC/WACC0.25
WACC9%
HZO Yearly LT Debt VS Equity VS FCFHZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • HZO has a Current Ratio of 1.19. This is a normal value and indicates that HZO is financially healthy and should not expect problems in meeting its short term obligations.
  • HZO has a Current ratio of 1.19. This is comparable to the rest of the industry: HZO outperforms 40.65% of its industry peers.
  • HZO has a Quick Ratio of 1.19. This is a bad value and indicates that HZO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.29, HZO is not doing good in the industry: 74.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.29
HZO Yearly Current Assets VS Current LiabilitesHZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for HZO have decreased strongly by -77.62% in the last year.
  • HZO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.26% yearly.
  • HZO shows a decrease in Revenue. In the last year, the revenue decreased by -1.10%.
  • HZO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.87% yearly.
EPS 1Y (TTM)-77.62%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-223.53%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%7.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 43.00% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 3.83% on average over the next years.
EPS Next Y12.44%
EPS Next 2Y35.78%
EPS Next 3Y43%
EPS Next 5YN/A
Revenue Next Year2.85%
Revenue Next 2Y3.44%
Revenue Next 3Y3.83%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HZO Yearly Revenue VS EstimatesHZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
HZO Yearly EPS VS EstimatesHZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 64.89, HZO can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as HZO.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, HZO is valued quite expensively.
  • With a Price/Forward Earnings ratio of 19.46, HZO is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, HZO is valued a bit cheaper than 66.67% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of HZO to the average of the S&P500 Index (28.06), we can say HZO is valued slightly cheaper.
Industry RankSector Rank
PE 64.89
Fwd PE 19.46
HZO Price Earnings VS Forward Price EarningsHZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • HZO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HZO is cheaper than 73.17% of the companies in the same industry.
  • HZO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HZO is cheaper than 96.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.64
EV/EBITDA 7.38
HZO Per share dataHZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HZO's earnings are expected to grow with 43.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.22
PEG (5Y)N/A
EPS Next 2Y35.78%
EPS Next 3Y43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HZO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MARINEMAX INC

NYSE:HZO (2/27/2026, 8:09:12 PM)

After market: 30.5 0 (0%)

30.5

+0.45 (+1.5%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners97.97%
Inst Owner Change-1.3%
Ins Owners2.85%
Ins Owner Change9.65%
Market Cap671.91M
Revenue(TTM)2.35B
Net Income(TTM)-57.62M
Analysts81.54
Price Target32.06 (5.11%)
Short Float %19.55%
Short Ratio10.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-81.02%
Min EPS beat(2)-230.66%
Max EPS beat(2)68.62%
EPS beat(4)2
Avg EPS beat(4)-34.43%
Min EPS beat(4)-230.66%
Max EPS beat(4)83.44%
EPS beat(8)4
Avg EPS beat(8)-4.44%
EPS beat(12)5
Avg EPS beat(12)-10.44%
EPS beat(16)8
Avg EPS beat(16)-4.53%
Revenue beat(2)2
Avg Revenue beat(2)2.95%
Min Revenue beat(2)2.61%
Max Revenue beat(2)3.28%
Revenue beat(4)3
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)0.38%
PT rev (1m)1.85%
PT rev (3m)-4.35%
EPS NQ rev (1m)-47.86%
EPS NQ rev (3m)-73.08%
EPS NY rev (1m)6.17%
EPS NY rev (3m)-49.92%
Revenue NQ rev (1m)2.42%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)0.89%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 64.89
Fwd PE 19.46
P/S 0.29
P/FCF 3.64
P/OCF 2.85
P/B 0.72
P/tB 1.81
EV/EBITDA 7.38
EPS(TTM)0.47
EY1.54%
EPS(NY)1.57
Fwd EY5.14%
FCF(TTM)8.38
FCFY27.48%
OCF(TTM)10.7
OCFY35.09%
SpS106.49
BVpS42.34
TBVpS16.84
PEG (NY)5.22
PEG (5Y)N/A
Graham Number21.16
Profitability
Industry RankSector Rank
ROA -2.37%
ROE -6.18%
ROCE 4.7%
ROIC 2.27%
ROICexc 2.45%
ROICexgc 3.41%
OM 2.94%
PM (TTM) N/A
GM 31.59%
FCFM 7.87%
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
ROICexc(3y)5.21%
ROICexc(5y)12.96%
ROICexgc(3y)7.5%
ROICexgc(5y)19.19%
ROCE(3y)9.35%
ROCE(5y)16.79%
ROICexgc growth 3Y-45.93%
ROICexgc growth 5Y-23.4%
ROICexc growth 3Y-45.55%
ROICexc growth 5Y-25.45%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 5.88
Debt/EBITDA 8.8
Cap/Depr 101.56%
Cap/Sales 2.18%
Interest Coverage 0.92
Cash Conversion 197.58%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.29
Altman-Z 1.84
F-Score5
WACC9%
ROIC/WACC0.25
Cap/Depr(3y)139.54%
Cap/Depr(5y)177.5%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.62%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-223.53%
EPS Next Y12.44%
EPS Next 2Y35.78%
EPS Next 3Y43%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%7.84%
Revenue Next Year2.85%
Revenue Next 2Y3.44%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y-53.43%
EBIT growth 3Y-27.02%
EBIT growth 5Y-1%
EBIT Next Year20.82%
EBIT Next 3Y19.63%
EBIT Next 5YN/A
FCF growth 1Y182.68%
FCF growth 3Y-12.94%
FCF growth 5Y-47.23%
OCF growth 1Y252.08%
OCF growth 3Y-1.68%
OCF growth 5Y-24.9%

MARINEMAX INC / HZO FAQ

Can you provide the ChartMill fundamental rating for MARINEMAX INC?

ChartMill assigns a fundamental rating of 3 / 10 to HZO.


What is the valuation status of MARINEMAX INC (HZO) stock?

ChartMill assigns a valuation rating of 4 / 10 to MARINEMAX INC (HZO). This can be considered as Fairly Valued.


Can you provide the profitability details for MARINEMAX INC?

MARINEMAX INC (HZO) has a profitability rating of 3 / 10.


Can you provide the financial health for HZO stock?

The financial health rating of MARINEMAX INC (HZO) is 3 / 10.